Evolus financials
$7.99+0.38%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $84.1M | $73.1M | $90.3M | $69.0M | $69.4M | $68.5M | $78.9M | $61.1M | $66.9M | $59.3M | $61.0M | $50.0M |
| Gross profit | $57.2M | $48.9M | $59.3M | $45.8M | $45.3M | $46.7M | $52.6M | $42.1M | $47.1M | $40.5M | $38.8M | $34.6M |
| Gross margin | 68.0% | 66.9% | 65.7% | 66.5% | 65.3% | 68.1% | 66.7% | 68.9% | 70.3% | 68.3% | 63.6% | 69.1% |
| Operating income | -$3.3M | -$6.8M | $4.2M | -$11.5M | -$14.1M | -$15.2M | -$2.3M | -$15.5M | -$7.7M | -$8.9M | -$13.8M | -$11.6M |
| Net income | -$8.1M | -$10.7M | $130.0K | -$15.7M | -$17.1M | -$18.9M | -$6.8M | -$19.2M | -$11.3M | -$13.1M | -$11.8M | -$16.9M |
| Net margin | −9.6% | −14.6% | 0.1% | −22.8% | −24.7% | −27.6% | −8.6% | −31.4% | −17.0% | −22.1% | −19.4% | −33.8% |
| Diluted EPS | $-0.12 | $-0.16 | $0.00 | $-0.24 | $-0.27 | $-0.30 | $-0.11 | $-0.30 | $-0.18 | $-0.22 | $-0.21 | $-0.30 |
| EBITDA | -$957.0K | -$4.5M | $6.5M | -$8.1M | -$12.4M | -$13.6M | -$940.0K | -$14.4M | -$6.3M | -$5.9M | -$9.5M | -$10.3M |
| Operating cash flow | -$3.6M | -$10.0M | $12.8M | -$14.7M | -$24.8M | -$15.6M | $4.8M | -$5.7M | -$6.5M | -$10.6M | $813.0K | -$924.0K |
| Free cash flow | -$3.6M | -$10.4M | $10.7M | -$16.8M | -$25.5M | -$16.0M | $3.4M | -$7.1M | -$7.7M | -$11.4M | $452.0K | -$1.5M |
| Diluted shares | 65.9M | 65.2M | 64.9M | 64.7M | 64.5M | 63.7M | 63.4M | 63.1M | 62.7M | 58.8M | 57.3M | 57.0M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $45.2M | $49.8M | $53.8M | $43.5M | $61.7M | $67.9M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $187.1M | $186.7M | $179.6M | $171.7M | $145.5M | $154.9M |
| Total assets | $248.0M | $220.6M | $225.9M | $219.0M | $228.8M | $213.4M |
| Total liabilities | $278.9M | $249.4M | $249.0M | $247.8M | $247.5M | $220.0M |
| Shareholders' equity | -$30.9M | -$28.8M | -$23.1M | -$28.8M | -$18.7M | -$6.6M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology